Episode

CAR-T clears path for transplants & AI-designed coronavirus vaccine tested - News (Jun 5, 2026)

Podcast
The Automated Daily
Published
Jun 5, 2026
Duration seconds
555
Processing state
not_requested
Canonical source
https://theautomateddaily.com/episodes/2026-06-05-car-t-clears-path-for-transplants-ai-designed-coronavirus-vaccine-tested
Audio
https://dts.podtrac.com/redirect.mp3/cdn.theautomateddaily.com/audio/news/2026-06-05/en/episode.mp3
JSON
/v1/public/podcasts/the-automated-daily-6466996/episodes/car-t-clears-path-for-transplants-ai-designed-coronavirus-vaccine-tested-news-jun-5-2026
Markdown
/podcast/the-automated-daily-6466996/car-t-clears-path-for-transplants-ai-designed-coronavirus-vaccine-tested-news-jun-5-2026.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-automated-daily-6466996/episodes/car-t-clears-path-for-transplants-ai-designed-coronavirus-vaccine-tested-news-jun-5-2026/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-automated-daily-6466996/car-t-clears-path-for-transplants-ai-designed-coronavirus-vaccine-tested-news-jun-5-2026.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Please support this podcast by checking out our sponsors: - Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron - Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: CAR-T clears path for transplants - Engineered CAR-T cells helped highly sensitized kidney patients receive transplants by reducing antibody-driven rejection risk, potentially expanding access beyond dialysis. AI-designed coronavirus vaccine tested - Cambridge researchers tested an AI-designed “super-antigen” coronavirus vaccine concept in humans, aiming for broad protection against future variants and spillovers. GLP-1 drugs and cancer signals - ASCO-presented studies suggest GLP-1 medicines may correlate with lower cancer risk and improved outcomes, prompting calls for randomized clinical trials and careful safety review. Lenacapavir injection for HIV prevention - South Africa is rolling out twice-yearly Lenacapavir for HIV prevention, a long-acting PrEP option that could boost adherence and reduce new infections. EU pushes tech sovereignty laws - The European Commission proposed a Technological Sovereignty Package covering chips, cloud, AI, and open source to reduce dependence on non-EU suppliers and secure critical services. Canada’s AI plan and sovereignty - Canada’s national AI strategy includes billions for AI literacy, domestic computing capacity, and talent retention, while critics say safety and online protections are still vague. US–Japan AI research partnership - Japan and the US launched a $1 billion initiative to speed R&D using AI, including a…